On behalf of the NHS Greater Manchester Green Plan Oversight Group, we now seek comments on a proposal for an active switch from Ventolin Metered-Dose Inhaler (MDI) or generic salbutamol MDI to Salamol MDI in primary care.

This consultation will run for six weeks and is open until 5pm on Thursday 16th May 2024. To take part, visit the consultations page.